Adverse events · people with postpolio syndrome
1 finding from 1 review
Wound infection · patients with ulnar neuropathy at the elbow
Simple decompression probably leads to lower adverse events: proportion of participants with deep/superficial… compared with transposition (moderate certainty).
1 finding from 1 review
Adverse events · people with motor neuron disease/amyotrophic lateral sclerosis with sialorrhea (excessive saliva) (all fed via gastrostomy and most…
1 finding from 1 review
no estimate extracted
10 participants
Very low
Intervention not reported
Adverse events · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review
no estimate extracted
1 study · 5 participants
Low
Intervention not reported
Adverse events · participants with CTEV at initial presentation
The intervention may leads to lower adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with pain in major depressive disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · 50‐ to 60‐year‐old women with metabolic syndrome
1 finding from 1 review
Adverse events · older adults with lower limb muscle cramps
1 finding from 1 review
Adverse events · older adults with lower limb muscle cramps
1 finding from 1 review
Adverse events · boys (aged 8 to 16 years old) with subclinical cardiomyopathy in DMD
1 finding from 1 review
Adverse events · boys with DMD and left ventricular ejection fraction 45% or more
It is very uncertain whether eplerenone (25 mg daily) changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · people with DMD or BMD (ages not stated)
1 finding from 1 review
Adverse events · boys with DMD, normal cardiac examination and LVEF > 55% at baseline
Prophylactic perindopril (2 mg to 4 mg daily) showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · patients with established cardiomyopathy in DMD
1 finding from 1 review
Intervention not reported
Adverse events · patients with diabetic neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Major adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
It is very uncertain whether the intervention changes major adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in minor adverse events (low certainty).
1 finding from 1 review
Serious adverse events · people with CIDP
Intravenous immunoglobulin showed no clear difference in serious adverse events compared with prednisolone (moderate certainty).
1 finding from 1 review
Serious adverse events · people with CIDP
Intravenous immunoglobulin showed no clear difference in serious adverse events compared with intravenous methylprednisolone (moderate certainty).
1 finding from 1 review
Intervention not reported
Other adverse events · patients with diabetic neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found